InsiderSignal.AI

InsiderSignal.ai

LPCN - Lipocine Inc.

Insider Purchase by Higuchi John W. (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

Yesterday, Higuchi John W., serving as Dir at Lipocine Inc. (LPCN), purchased 40,000 shares at $2.03 per share, for a total transaction value of $81,200.00. Following this transaction, Higuchi John W. now holds 203,797 shares of LPCN.

This purchase represents a 24.00% increase in Higuchi John W.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 7, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, April 7, 2026, meaning the disclosure happened on the same day as the trade.

Lipocine Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Higuchi John W.

Higuchi John W.

Dir

John W. Higuchi is a Director at Lipocine Inc. (NASDAQ: LPCN), a position he has held since 2002.[[1]](https://ois.net/john-higuchi/)[[3]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lpcn/lipocine/management)[[7]](https://uk.marketscreener.com/quote/stock/LIPOCINE-INC-16085349/company-governance/) He previously served as Vice President of Business Development and Corporate Treasurer at Lipocine and co-founded Theratech Inc., a transdermal drug delivery company, where he acted as Chairman.[[1]](https://ois.net/john-higuchi/)[[2]](https://ir.lipocine.com/LIPOCINE-CHAIRMAN-AWARDED-PRESTIGIOUS-ORDER-OF-THE-RISING-SUN-BY-THE-JAPANESE-GOVERNMENT) Currently, Higuchi serves as CEO of Aciont and is a co-founder and board member of Spriaso, LLC, which develops respiratory and primary care products, including an FDA-approved combination drug for respiratory therapy.[[1]](https://ois.net/john-higuchi/)[[6]](https://www.zoominfo.com/p/John-Higuchi/1532729053) On April 6, 2026, he purchased 123,000 shares of Lipocine stock at $2.05 per share, increasing his direct ownership to 163,797 shares.[[4]](https://www.investing.com/news/insider-trading-news/higuchi-john-w-buys-lipocine-lpcn-shares-worth-252149-93CH-4599557) Higuchi holds a BS in Chemistry from Hope College and an MBA and MS in Information Systems from The George Washington University.[[1]](https://ois.net/john-higuchi/)

View full insider profile →

Trade Price

$2.03

Quantity

40,000

Total Value

$81,200.00

Shares Owned

203,797

Trade Date

Tuesday, April 7, 2026

1 days ago

SEC Filing Date

Tuesday, April 7, 2026

HEALTHCAREBIOTECHNOLOGY

About Lipocine Inc.

Company Overview

No company information available
View news mentioning LPCN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5448251

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime